Showing results (81-90 of 193) with videos related to
Sort By:
Pageof 20
Advances in Neurology|January 1, 1978
Evidence for a primary defect of lipoamide dehydrogenase in Friedreich's ataxiaR A Kark, M Rodriguez-Budelli, J P BlassJournal of the Neurological Sciences|December 1, 1996
Absence of neuronal and glial proteins in human and rat leptomeninges in situN Y Calingasan, J J Bernstein, J P BlassJournal of Neurochemistry|May 1, 1983
Pyruvate dehydrogenase phosphate (PDHb) phosphatase in brain: activity, properties, and subcellular localizationK F Sheu, J C Lai, J P BlassJournal of Neurochemistry|January 1, 1984
Properties and regional distribution of pyruvate dehydrogenase kinase in rat brainK F Sheu, J C Lai, J P BlassClinica Chimica Acta; International Journal of Clinical Chemistry|February 15, 1977
Rapid diagnosis of pyruvate and ketoglutarate dehydrogenase deficiencies in platelet-enriched preparations from bloodJ P Blass, S D Cederbaum, R A KarkThe American Journal of Pathology|September 1, 1991
Immunohistochemical colocalization of amyloid precursor protein with cerebrovascular amyloid of Alzheimer's diseaseL W Ko, K F Sheu, J P BlassBiological Psychiatry|February 1, 1985
Cerebral blood flow decrements in chronic head injury syndromeL Barclay, A Zemcov, W Reichert, et al.Neurobiology of Aging|May 1, 1986
Human red blood cell choline uptake with age and Alzheimer's diseaseK A Sherman, G E Gibson, J P BlassClinical Neuropharmacology|February 1, 1990
L-deprenyl, levodopa pharmacokinetics, and response fluctuations in Parkinson's diseaseJ M Cedarbaum, M Silvestri, M Clark, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Sustained-release (+)-PHNO [MK-458 (HPMC)] in the treatment of Parkinson's disease: evidence for tolerance to a selective D2-receptor agonist administered as a long-acting formulationJ M Cedarbaum, M Clark, L H Toy, et al.Pageof 20